A Trial of Tivozanib (AV-951) in Combination With Capecitabine (Xeloda®) in Subjects With Advanced Solid Tumors

Clinical trial NCT01306630 · COMPLETED

Trial details

NCT number: NCT01306630
Sponsor: AVEO Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors Locally Advanced or Metastatic Breast or Colorectal Cancer

Start date: 2010-11-01
Primary completion: 2014-01-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.